Pricing Log in Create free account

Lipella Pharmaceuticals Inc. (LIPO) vs Panbela Therapeutics Inc. (PBLA)

Lipella Pharmaceuticals Inc. and Panbela Therapeutics Inc. are both Biotechnology companies. Lipella Pharmaceuticals Inc. and Panbela Therapeutics Inc. are of similar size ($3.4M and $3.4M). Across the 6 metrics below, Panbela Therapeutics Inc. leads on 4 and Lipella Pharmaceuticals Inc. on 2.

Valuation

Metric LIPO PBLA Biotechnology median
P/E n/m n/m 8.50
P/S n/m n/m 9.71
P/B n/m n/m 2.13
Price to free cash flow n/m n/m 20.82
EV/EBITDA 0.29 n/m 0.64
EV/Sales (3.31) n/m 9.21
Earnings yield 0.00% 0.00% (33.15%)
Free cash flow yield 0.00% 0.00% (25.50%)

Profitability

Metric LIPO PBLA Biotechnology median
Gross margin 100.00% — 65.16%
Operating margin 0.00% 0.00% 0.00%
Net margin 0.00% 0.00% 0.00%
Free cash flow margin 0.00% 0.00% 0.00%
Return on equity (361.77%) 270.37% (56.36%)
Return on assets (236.36%) (353.47%) (48.04%)
Return on invested capital 0.00% 0.00% 0.00%

Growth

Metric LIPO PBLA Biotechnology median
Revenue growth (TTM) (7.29%) — 6.02%
EPS growth (last fiscal year) 22.24% 99.43% 30.26%
Revenue growth, 5-year CAGR (5.04%) — 9.41%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric LIPO PBLA Biotechnology median
Debt to equity 0.00 (0.23) 0.00
Current ratio 3.24 0.26 4.72
Net debt to EBITDA 0.43 (0.10) 0.96

Dividend

Metric LIPO PBLA Biotechnology median
Dividend yield — — 0.09%
Payout ratio — — —

Size

Metric LIPO PBLA Biotechnology median
Market cap 3.39m 3.35m 135.18m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack